Tetracycline-dependent expression of the human erythropoietin gene in transgenic chickens

Transgenic Research

Volumn 19, Issue 3, 2010, Pages 437-447

  Koo, Bon Chul ^a   Kwon, Mo Sun ^a   Lee, Hyuna ^a   Kim, Minjee ^a   Kim, Dohyang ^a   Roh, Ji Yeol ^b   Park, Yoon Yub ^a   Cui, Xiang Shun ^b   Kim, Nam Hyung ^b   Byun, Sung June ^c   Kim, Teoan ^a  

^a Catholic University of Daegu   (South Korea)

^b Chungbuk National University   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

Human erythropoietin (hEPO); Retrovirus vector; Tetracycline controlled promoter; Transgenic chicken

Indexed keywords

ERYTHROPOIETIN; G PROTEIN, VESICULAR STOMATITIS VIRUS; MEMBRANE PROTEIN; PRIMER DNA; TETRACYCLINE; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; CHICKEN; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MOLONEY LEUKEMIA ONCOVIRUS; PROMOTER REGION; STATISTICAL MODEL; TRANSGENIC ANIMAL; DRUG EFFECTS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHICKENS; DNA PRIMERS; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LINEAR MODELS; MEMBRANE GLYCOPROTEINS; MOLONEY MURINE LEUKEMIA VIRUS; PROMOTER REGIONS, GENETIC; TETRACYCLINE; VIRAL ENVELOPE PROTEINS;

ANIMALIA; GALLUS GALLUS; MOLONEY MURINE LEUKEMIA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 77952237026     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-009-9327-3     Document Type: Article

References (39)

1. Bäckman CM, Zhang Y, Hoffer BJ, Tomac AC (2004) Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vector. J Neurosci Methods 30: 257-262.
2. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90: 8033-8037.
3. Chapman SC, Lawson A, MacArthur WC, Wiese RJ, Loechel RH, Burgos-Trinidad M, Wakefield JK, Ramabhadran R, Mauch TJ, Shoenwolf GC (2005) Ubiquitous GFP expression in transgenic chickens using a lentiviral vector. Development 132: 935-940.
4. Choi BR, Koo BC, Ahn KS, Kwon MS, Kim J-H, Cho S-K, Kim KM, Kang JH, Shim H, Lee H, Uhm SJ, Lee HT, Kim T (2006) Tetracycline-inducible gene expression in nuclear transfer embryos derived from porcine fetal fibroblasts transformed with retrovirus vectors. Mol Reprod Dev 73: 1221-1229.
5. Eyal-Giladi H, Kochav S (1976) From cleavage to primitive streak formation: a complementary normal table and a new look at the first stages of the development of the chick. Dev Biol 49: 321-337.
6. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
7. Harvey AJ, Speksnijder G, Baugh LR, Morris JA, Ivarie R (2002) Expression of exogenous protein in the egg white of transgenic chickens. Nat Biotechnol 20: 396-399.
8. Houdebine LM (2009) Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 32: 107-121.
9. Ivarie R (2003) Avian transgenesis: progress towards the promise. Trends Biotechnol 21: 14-19.
10. Jelkmann W (2004) Molecular biology of erythropoietin. Intern Med 43: 649-659.
11. Jelkmann W (2007) Erythropoietin after a century of research: younger than ever. Eur J Haematol 78: 183-205.
12. Jelkmann W (2008) Developments in the therapeutic use of erythropoiesis stimulating agent. Br J Haematol 141: 287-297.
13. Kamihira M, Ono KI, Esaka K, Nishijima KI, Kigaku R, Komatsu H, Yamashita T, Kyogoku K, Iijima S (2005) High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector. J Virol 79: 10864-10874.
14. Kaushansky K (2006) Lineage-specific hematopoietic growth factors. N Engl J Med 354: 2034-2045.
15. Kim T (2002) Transgenic chickens as bioreactors for protein-based drugs. In: Pinkert CA (ed) Transgenic animal technology, 2nd edn. Academic Press, San Diego, pp 173-193.
16. Kitamura T, Tnage T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaru F (1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140: 323-334.
17. Kodama D, Nishimiya D, Iwata K, Yamaguchi K, Yoshida K, Kawabe Y, Motono M, Watanabe H, Yamashita T, Nishima K, Kamihira M, Iijima S (2008) Production of human erythropoietin by chimeric chickens. Biochem Biophys Res Commun 367: 834-839.
18. Koo BC, Kwon MS, Choi BR, Kim JH, Cho SK, Sohn SH, Cho EJ, Lee HT, Chang W, Jeon I, Park JK, Park JB, Kim T (2006) Production of germline transgenic chickens expressing enhanced green fluorescent protein using a MoMLV-based retrovirus vector. FASEB J 20: 2251-2260.
19. Kues WA, Schwinzer R, Wirth D, Verhoeyen E, Lemme E, Herrmann D, Barg-Kues B, Hauser H, Wonigeit K, Niemann H (2006) Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double-transgenic pigs. FASEB J 20: 1200-1202.
20. Lamartina S, Silvi L, Roscilli G, Casimiro D, Simon AJ, Davies ME, Shiver JW, Rinaudo CD, Zampaglione I, Fattori E, Colloca S, Gonzalez Paz O, Laufer R, Bujard H, Cortese R, Ciliberto G, Toniatti C (2003) Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. Mol Ther 7: 271-280.
21. Lillico SG, Mcgrew MJ, Sherman A, Sang HM (2005) Transgenic chickens as bioreactors for protein-based drugs. Drug Discov Today 10: 191-196.
22. Lillico SG, Sherman A, Mcgrew MJ, Robertson CD, Smith J, Haslam C, Barnard P, Radcliffe PA, Mitrophanous KA, Elliot EA, Sang HM (2007) Oviduct-specific expression of two therapeutic proteins in transgenic hens. Proc Natl Acad Sci USA 104: 1771-1776.
23. Longhurst H (2008) Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and certebral ischemia. Curr Opin Investig Drugs 9: 310-323.
24. Marsden JT (2006) Erythropoietin-measurement and clinical applications. Ann Clin Biochem 43: 97-104.
25. McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H (2004) Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep 5: 728-733.
26. Niemann H, Kues W (2003) Application of transgenesis in livestock for agriculture and biomedicine. Anim Reprod Sci 79: 291-317.
27. Niemann H, Kues W (2007) Trangenic farm animals: an update. Reprod Fertil Dev 19: 762-770.
28. Nordqvist C (2009) Blood clotting drug, ATryn, from genetically engineered goats approved by FDA. In: Medical News Today, MediLexicon Intnl, LTD.
29. Petitte JN, Mozdziak PE (2002) Transgenic chickens as bioreactors for protein-based drugs. In: Pinkert CA (ed) Transgenic animal technology, 2nd edn. Academic Press, San Diego, pp 279-306.
30. Popa I, Harris ME, Donello JE, Hope TJ (2002) CRM1-dependent function of a cis-acting RNA export element. Mol Cell Biol 22: 2057-2067.
31. Raju TS, Briggs JB, Borge SM, Jones AJ (2000) Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10: 477-486.
32. Rapp JC, Harvey AJ, Speksnijder GL, Hu W, Ivarie R (2003) Biologically active human interferon α-2b produced in the egg white of transgenic hens. Transgenic Res 12: 569-575.
33. Rivière I, Sadelain M (1997) Methods or the construction of retrovirus vectors and generation of high-titer producers. In: Robbins PD (ed) Gene therapy protocol. Humana, Totowa, pp 59-78.
34. Ryding AD, Sharp MG, Mullins JJ (2001) Conditional transgenic technologies. J Endocrinol 171: 1-14.
35. Sinn PL, Sauter SL, McCray PB Jr (2005) Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12: 1089-1098.
36. Steinlein P, Deiner E, Leutz A, Beug H (1994) Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro. Growth Factors 10: 1-16.
37. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97: 7963-7968.
38. Zhu L, van de Lavoir MC, Albanese J, Beenhouwer DO, Cardarelli PM, Cuison S, Deng DF, Deshpande S, Diamond JH, Green L et al (2005) Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol 23: 1159-1169.
39. Zufferey R, Donello JE, Trono D, Hope TJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886-2892.